With $9 billion in facility-specific investment and 900 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- Eli Lilly
- Industry
- Pharmaceuticals
- Location
- Lebanon, Indiana
- Investment
- $9.00B
- Permanent jobs announced
- 900
- Status
- Under Construction
- Announced
- May 24, 2022
- Expected opening
- Jan 1, 2027
- Added to tracker
- Apr 15, 2025
Official references
- Primary source https://iedc.in.gov/events/news/details/2024/05/24/gov.-holcomb-joins-lilly-to-announce-additional-5.3-billion-investment-at-leap-district
Other projects to know
- PharmaceuticalsEli LillyLebanon, Indiana$4.50BNo separate jobs count announced.
- Industrial Machinery & EquipmentAmazonGreenwood, Indiana$100.0M300 jobs
- Medical Devices & DiagnosticsRoche Group (Roche Diagnostics)Indianapolis, Indiana$550.0M650 jobs
- PharmaceuticalsEli LillyLebanon, Indiana$4.50B400 jobs